1. Turner JR, Durham TA (2009) Integrated cardiac safety: assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance. Wiley, Hoboken
2. Kay R (2007) Statistical thinking for non-statisticians in drug regulation. Wiley, Chichester
3. Kaul S (2011) Cardiovascular safety in drug development: state-of-the-art assessment. Presentation given at the DIA/FDA/CSRC-sponsored meeting, April 14. Washington DC
4. Turner JR (2011) Editor’s Commentary: Additional Associate Editors, New Submission Category, and Meta-methodology. Drug Inform J 45:221–227
5. Turner JR, Satin LZ, Callahan T, Litwin J (2010) The science of cardiac safety. Appl Clin Trials 19(Suppl 11):4–8, 11